PG
ELV icon

Pendal Group’s Elevance Health ELV Stock Holding History

Pendal Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,915
Closed -$1.5M – 469
2017
Q3 		$1.5M Buy
+7,915
New +$1.51M 0.02% 254

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pendal Group's ELV Position: Q4 2022 in Review

Pendal Group reduced its Elevance Health (ELV) stake by 8.2% in Q4 2022, selling an estimated $19.6M and leaving 432,785 shares worth $222M. The position accounts for 1.92% of the portfolio, ranked #11.

Pendal Group first reported a position in ELV in Q2 2017 and has held it in 23 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Pendal Group held 432,785 shares of Elevance Health worth $222M as of Q4 2022.
  • Pendal Group sold 38,588 Elevance Health shares in Q4 2022, an estimated $19.6M.
  • Elevance Health made up 1.92% of Pendal Group's portfolio in Q4 2022, its #11 holding.
  • Pendal Group first reported a position in Elevance Health in Q2 2017 and has held it in 23 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.